2 ML anifrolumab-fnia 150 MG/ML Injection

RxCUI: 2565280
RxNorm name: 2 ML anifrolumab-fnia 150 MG/ML Injection
Display name: 2 ML anifrolumab-fnia 150 MG/ML Injection
Full name: 2 ML anifrolumab-fnia 150 MG/ML Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761123	Saphnelo	anifrolumab-fnia	351(a)	Rx	2026-08-01
761451	Saphnelo	anifrolumab-fnia	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SAPHNELO	ANIFROLUMAB-FNIA	AstraZeneca Pharmaceuticals LP	d6203302-2128-41a7-b0b4-0e6c0704d4dc	2026-04-24	Warnings, Adverse reactions	Exact identifier rxcui: 2565280

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
d6203302-2128-41a7-b0b4-0e6c0704d4dc	anifrolumab-fnia 300 MG in 2 ML Injection [PSN] · 2 ML anifrolumab-fnia 150 MG/ML Injection [SCD] · anifrolumab-fnia 300 MG per 2 ML Injection [SY]	3	15	These highlights do not include all the information needed to use SAPHNELO ® safely and effectively. See full prescribing information for SAPHNELO. SAPHNELO (anifrolumab-fnia) injection, for intravenous, or subcutaneous use Initial U.S. Approval: 2021	20260424